Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study-Reference-Cited by-同舟云学术

Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study

Published:2021-02 Issue:5 Volume:123 Page:1263-1273
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Behrenbruch C.¹²³^ORCID,Prabhakaran S.²,Udayasiri D D.²⁴⁵,Michael M.¹⁶,Hollande F.³⁷,Hayes I.²⁴⁵,Heriot A. G.¹⁸⁹,Knowles B.²,Thomson B. N.²⁸⁴

Affiliation:

1. Sir Peter MacCallum Department of Oncology, Victorian Comprehensive Cancer Centre The University of Melbourne Melbourne Australia

2. Department of General Surgical Specialties The Royal Melbourne Hospital Parkville Australia

3. Department of Clinical Pathology, Victorian Comprehensive Cancer Centre The University of Melbourne Melbourne Australia

4. Department of Surgery, Royal Melbourne Hospital The University of Melbourne Parkville Australia

5. Colorectal Surgery Unit The Royal Melbourne Hospital Parkville Australia

6. Department of Medical Oncology, Victorian Comprehensive Cancer Centre Peter MacCallum Cancer Centre Melbourne Australia

7. Centre for Cancer Research, Victorian Comprehensive Cancer Centre University of Melbourne Melbourne Australia

8. Department of Cancer Surgery, Peter MacCallum Cancer Centre Victorian Comprehensive Cancer Centre Melbourne Australia

9. Department of Surgery, St Vincent's Hospital The University of Melbourne Fitzroy Australia

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26400

Reference52 articles.

1. Relative survival by stage at diagnosis (colorectal cancer).2019;https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/relative-survival-stage-diagnosis-colorectal-cancer. Accessed 16th August 2020.

2. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors;Rawla P;Prz Gastroenterol,2019

3. Multidisciplinary approach of liver metastases from colorectal cancer

4. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

5. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Objective Definition and Optimized Strategy for “Biologically Borderline Resectable” Colorectal Liver Metastases;World Journal of Surgery;2023-08-04

2. Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis;Academic Radiology;2022-12

3. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy;Annals of Surgical Oncology;2022-01-11

4. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study;International Journal of Surgery;2021-10

5. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study;Journal of Surgical Oncology;2021-02